Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1698444

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1698444

Global Cardiac Mapping Market - Forecasts from 2025 to 2030

PUBLISHED:
PAGES: 147 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multiple User License)
USD 4550
PDF (Enterprise License)
USD 6950

Add to Cart

The global cardiac mapping market is estimated at US$1,423.559 million in 2025 and is expected to grow at a CAGR of 9.99% to attain US$2,291.392 million in 2030.

Cardiac mapping is the study of electrophysiology or EP. The cardiac mapping process helps in identifying various types of temporal and spatial distribution in the heart. This system also helps in accurately recognizing various sites of abnormal rhythm and delivers radio-frequency catheter ablation therapy. The increasing global prevalence of cardiovascular diseases is the major factor propelling this market's growth during the forecasted timeline. Similarly, technological advancements in cardiac mapping devices are also estimated to propel market expansion. New and effective techniques for the successful treatment of atrial fibrillation are offering market players valuable opportunities to enhance their competitive position and accelerate overall market growth.

Market Trends:

  • Rising Global Cardiovascular Disease Cases: The increasing prevalence of cardiovascular diseases, such as arrhythmias, heart attacks, and coronary artery disease, is a key driver of the cardiac mapping market. According to the U.S. Centers for Disease Control and Prevention (CDC), there were 702,880 recorded cases of cardiovascular diseases in 2022, highlighting the growing demand for advanced cardiac mapping solutions.
  • Technological Advancements: Innovations in medical technology are enhancing the accuracy and efficiency of cardiac mapping systems, driving their demand. These advancements are making cardiac mapping more effective and accessible, contributing to market growth.
  • Improved Healthcare Infrastructure and Government Policies: Global improvements in healthcare infrastructure, along with supportive government policies, are significant factors boosting the development and adoption of cardiac mapping systems.
  • North America's Market Leadership: North America is expected to hold a substantial share of the cardiac mapping market during the forecast period. This is due to the region's well-established healthcare industry, availability of high-quality medical services, and early adoption of advanced medical devices. Additionally, the growing elderly population and increased risk of heart-related issues in countries like the U.S. are driving demand for cardiac mapping systems.

Some of the major players covered in this report include Biosense Webster, Inc., Medtronic, Abbott, BIOTRONIK SE & Co KG, Acutus Medical, Boston Scientific Corporation, AMETEK Inc., Catheter Precision Inc., Medical Device Business Services, Inc. (Johnson&Johnson), MicroPort Scientific Corporation, Koninklijke Philips N.V, and Kardium Inc. among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Global Cardiac Mapping Market is analyzed into the following segments:

By Product

  • EP Ablation Catheters
  • EP Laboratory Devices
  • EP Diagnostic Catheters
  • Access Devices

By Indication

  • Atrial Fibrillation
  • Atrial Flutter
  • Atrioventricular Nodal Re-entry Tachycardia
  • Wolff-Parkinson-White Syndrome

By End-User

  • Hospitals and Clinics
  • Diagnostic Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Product Code: KSI061613782

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CARDIAC MAPPING MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. EP Ablation Catheters
  • 5.3. EP Laboratory Devices
  • 5.4. EP Diagnostic Catheters
  • 5.5. Access Devices

6. GLOBAL CARDIAC MAPPING MARKET BY INDICATION

  • 6.1. Introduction
  • 6.2. Atrial Fibrillation
  • 6.3. Atrial Flutter
  • 6.4. Atrioventricular Nodal Re-entry Tachycardia
  • 6.5. Wolff-Parkinson-White Syndrome

7. GLOBAL CARDIAC MAPPING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Diagnostic Centers

8. GLOBAL CARDIAC MAPPING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product
    • 8.3.2. By Indication
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product
    • 8.4.2. By Indication
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product
    • 8.5.2. By Indication
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product
    • 8.6.2. By Indication
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Biosense Webster, Inc.
  • 10.2. Medtronic
  • 10.3. Abbott
  • 10.4. BIOTRONIK SE & Co. KG
  • 10.5. Acutus Medical
  • 10.6. Boston Scientific Corporation
  • 10.7. AMETEK Inc.
  • 10.8. Catheter Precision Inc.
  • 10.9. Medical Device Business Services, Inc. (Johnson & Johnson)
  • 10.10. MicroPort Scientific Corporation
  • 10.11. Koninklijke Philips N.V.
  • 10.12. Kardium Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!